Global Varicella Attenuated Live Vaccine Consumption 2016 Market Research Report
- QYR659691
- 162 Pages
- August 2016
- Pharmaceuticals
First, the report provides a basic overview of the Varicella Attenuated Live Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.
Secondly, the report states the global Varicella Attenuated Live Vaccine market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed.
Third, the Varicella Attenuated Live Vaccine market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Varicella Attenuated Live Vaccine industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview of Varicella Attenuated Live Vaccine 1
1.1 Definition and Specifications of Varicella Attenuated Live Vaccine 1
1.1.1 Definition of Varicella Attenuated Live Vaccine 1
1.1.2 Introduction of Varicella Attenuated Live Vaccine 1
1.2 Classification of Varicella Attenuated Live Vaccine 2
1.2.1 Monovalent Vaccine 3
1.2.2 Combination Vaccine 4
1.3 Applications of Varicella Attenuated Live Vaccine 4
1.3.1 Kids Injection 5
1.3.2 Adults Injection 6
1.4 Industry Chain Structure of Varicella Attenuated Live Vaccine 6
1.5 Industry Overview and Major Regions Status of Varicella Attenuated Live Vaccine 7
1.5.1 Industry Overview of Varicella Attenuated Live Vaccine 7
1.5.2 Global Major Regions Status of Varicella Attenuated Live Vaccine 7
1.6 Industry Policy Analysis of Varicella Attenuated Live Vaccine 7
1.7 Industry News Analysis of Varicella Attenuated Live Vaccine 9
2 Manufacturing Cost Structure Analysis of Varicella Attenuated Live Vaccine 11
2.1 Raw Material Introduction of Varicella Attenuated Live Vaccine 11
2.2 Equipment Suppliers of Varicella Attenuated Live Vaccine 11
2.3 Labor Cost Analysis of Varicella Attenuated Live Vaccine 12
2.4 Other Costs Analysis of Varicella Attenuated Live Vaccine 15
2.5 Manufacturing Cost Structure Analysis of Varicella Attenuated Live Vaccine 19
2.6 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine 20
3 Technical Data and Manufacturing Plants Analysis of Varicella Attenuated Live Vaccine 21
3.1 Sales Volume and Established date of Global Varicella Attenuated Live Vaccine Major Manufacturers in 2015 21
3.2 Manufacturing Plants Distribution of Global Varicella Attenuated Live Vaccine Major Manufacturers in 2015 21
3.3 R&D Status and Technology Source of Global Varicella Attenuated Live Vaccine Major Manufacturers in 2015 22
3.4 Raw Materials Sources Analysis of Global Varicella Attenuated Live Vaccine Major Manufacturers in 2015 23
4 Global Market Size (Volume and Value), Sales and Sale Price Analysis of Varicella Attenuated Live Vaccine 24
4.1 Global Market Size (Volume and Value) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 24
4.2 Global Market Size (Volume and Value) of Varicella Attenuated Live Vaccine by Regions 2011-2016 25
4.3 Global Market Size of Varicella Attenuated Live Vaccine by Types 2011-2016 28
4.4 Global Market Size of Varicella Attenuated Live Vaccine by Applications 2011-2016 30
4.5 Global Sales Volume and Sales Revenue of Varicella Attenuated Live Vaccine by Companies 2011-2016 32
4.6 Global Sale Price of Varicella Attenuated Live Vaccine by Regions 2011-2016 36
4.7 Global Sale Price of Varicella Attenuated Live Vaccine by Companies 2011-2016 37
5 USA Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Varicella Attenuated Live Vaccine 39
5.1 USA Market Size (Volume and Value) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 39
5.2 USA Market Size of Varicella Attenuated Live Vaccine by Types 2011-2016 40
5.3 USA Market Size of Varicella Attenuated Live Vaccine by Applications 2011-2016 42
5.4 USA Sales Volume and Sales Revenue of Varicella Attenuated Live Vaccine by Companies 2011-2016 44
5.5 USA Sale Price of Varicella Attenuated Live Vaccine by Companies 2011-2016 46
5.6 USA Regional Supply, Import, Export and Consumption of Varicella Attenuated Live Vaccine 2011-2016 47
6 Europe Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Varicella Attenuated Live Vaccine 48
6.1 Europe Market Size (Volume and Value) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 48
6.2 Europe Market Size (Volume) of Varicella Attenuated Live Vaccine by Types 2011-2016 49
6.3 Europe Market Size (Volume) of Varicella Attenuated Live Vaccine by Applications 2011-2016 51
6.4 Europe Sales Volume and Sales Revenue of Varicella Attenuated Live Vaccine by Companies 2011-2016 52
6.5 Europe Sale Price of Varicella Attenuated Live Vaccine by Companies 2011-2016 55
6.6 Europe Regional Supply, Import, Export and Consumption of Varicella Attenuated Live Vaccine 2011-2016 56
7 China Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Varicella Attenuated Live Vaccine 57
7.1 China Market Size (Volume and Value) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 57
7.2 China Market Size (Volume) of Varicella Attenuated Live Vaccine by Types 2011-2016 58
7.3 China Market Size (Volume) of Varicella Attenuated Live Vaccine by Applications 2011-2016 60
7.4 China Sales Volume and Sales Revenue of Varicella Attenuated Live Vaccine by Companies 2011-2016 61
7.5 China Sale Price of Varicella Attenuated Live Vaccine by Companies 2011-2016 65
7.6 China Regional Supply, Import, Export and Consumption of Varicella Attenuated Live Vaccine 2011-2016 66
8 Japan Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Varicella Attenuated Live Vaccine 67
8.1 Japan Market Size (Volume and Value) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 67
8.2 Japan Market Size (Volume) of Varicella Attenuated Live Vaccine by Types 2011-2016 68
8.3 Japan Market Size (Volume) of Varicella Attenuated Live Vaccine by Applications 2011-2016 70
8.4 Japan Sales Volume and Sales Revenue of Varicella Attenuated Live Vaccine by Companies 2011-2016 71
8.5 Japan Sale Price of Varicella Attenuated Live Vaccine by Companies 2011-2016 74
8.6 Japan Regional Supply, Import, Export and Consumption of Varicella Attenuated Live Vaccine 2011-2016 75
9 Global 2011-2016E Varicella Attenuated Live Vaccine Segment Market Analysis (by Type) 76
9.1 Global 2011-2016E Varicella Attenuated Live Vaccine Sales Volume by Type 76
9.2 Different Types Varicella Attenuated Live Vaccine Product Driving Factors Analysis 76
9.2.1 Monovalent Varicella Attenuated Live Vaccine Growth Driving Factor Analysis 76
9.2.2 Combination Varicella Attenuated Live Vaccine Growth Driving Factor Analysis 76
10 Global 2011-2016E Varicella Attenuated Live Vaccine Segment Market Analysis (by Application) 78
10.1 Global 2011-2016E Varicella Attenuated Live Vaccine Consumption Volume by Application 78
10.2 Different Application Varicella Attenuated Live Vaccine Product Driving Factors Analysis 78
10.2.1 Kids Injection Varicella Attenuated Live Vaccine Growth Driving Factor Analysis 78
10.2.2 Adults Injection Varicella Attenuated Live Vaccine Growth Driving Factor Analysis 79
11 Major Companies Analysis of Varicella Attenuated Live Vaccine 80
11.1 Merck 80
11.1.1 Company Profile 80
11.1.2 Product Picture and Specifications 81
11.1.3 Sales Volume, Sales Revenue, Sale Price and Gross Margin 82
11.1.4 Merck Varicella Vaccine Business Region Distribution Analysis in 2015 83
11.2 GSK 84
11.2.1 Company Profile 84
11.2.2 Product Picture and Specifications 84
11.2.3 Sales Volume, Sales Revenue, Sale Price and Gross Margin 85
11.2.4 GSK Varicella Vaccine Business Region Distribution Analysis in 2015 86
11.3 Shanghai Institute 87
11.3.1 Company Profile 87
11.3.2 Product Picture and Specifications 87
11.3.3 Sales Volume, Sales Revenue, Sale Price and Gross Margin 88
11.3.4 Shanghai Institute Varicella Vaccine Business Region Distribution Analysis in 2015 89
11.4 BCHT 90
11.4.1 Company Profile 90
11.4.2 Product Picture and Specifications 90
11.4.3 Sales Volume, Sales Revenue, Sale Price and Gross Margin 91
11.4.4 BCHT Varicella Vaccine Business Region Distribution Analysis in 2015 92
11.5 Changsheng 93
11.5.1 Company Profile 93
11.5.2 Product Picture and Specifications 94
11.5.3 Sales Volume, Sales Revenue, Sale Price and Gross Margin 94
11.5.4 Changsheng Varicella Vaccine Business Region Distribution Analysis in 2015 96
11.6 Keygen 96
11.6.1 Company Profile 96
11.6.2 Product Picture and Specifications 97
11.6.3 Sales Volume, Sales Revenue, Sale Price and Gross Margin 97
11.6.4 Keygen Varicella Vaccine Business Region Distribution Analysis in 2015 98
11.7 Green Cross 99
11.7.1 Company Profile 99
11.7.2 Product Picture and Specifications 99
11.7.3 Sales Volume, Sales Revenue, Sale Price and Gross Margin 100
11.7.4 Green Cross Varicella Vaccine Business Region Distribution Analysis in 2015 101
11.8 Biken 102
11.8.1 Company Profile 102
11.8.2 Product Picture and Specifications 103
11.8.3 Sales Volume, Sales Revenue, Sale Price and Gross Margin 104
11.8.4 Biken Varicella Vaccine Business Region Distribution Analysis in 2015 105
12 Global Production Analysis of Varicella Attenuated Live Vaccine by Regions 106
12.1 Global Production of Varicella Attenuated Live Vaccine by Regions 2011-2016 106
12.2 Global Production Market Share of Varicella Attenuated Live Vaccine by Regions 2011-2016 106
13 Global and Major Regions Market Size (Volume and Value) Forecast of Varicella Attenuated Live Vaccine 108
13.1 Global and Major Regions Market Size (Volume and Value) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 108
13.2 Global Market Size (Volume and Value) of Varicella Attenuated Live Vaccine by Regions 2016-2021 113
13.3 Global and Major Regions Market Size of Varicella Attenuated Live Vaccine by Types 2016-2021 116
13.4 Global and Major Regions Market Size (Volume and Value) of Varicella Attenuated Live Vaccine by Applications 2016-2021 125
14 Marketing Trader or Distributor Analysis of Varicella Attenuated Live Vaccine 133
14.1 Regional Marketing Channels Status of Varicella Attenuated Live Vaccine 133
14.2 International Marketing Channels Status of Varicella Attenuated Live Vaccine 134
14.3 Traders or Distributors with Contact Information of Varicella Attenuated Live Vaccine by Regions 134
15 Industry Chain and Consumers Analysis of Varicella Attenuated Live Vaccine 136
15.1 Upstream Major Main Raw Materials Suppliers Analysis of Varicella Vaccine 136
15.2 Major Equipment Suppliers with Contact Information Analysis of Varicella Vaccine 137
15.3 Potential Consumer Analysis 138
16 New Project Investment Feasibility Analysis of Varicella Attenuated Live Vaccine 139
16.1 New Project SWOT Analysis of Varicella Attenuated Live Vaccine 139
16.2 New Project Investment Feasibility Analysis of Varicella Attenuated Live Vaccine 139
17 Conclusion of the Global Varicella Attenuated Live Vaccine Consumption 2016 Market Research Report 141
Figure Picture of Varicella Attenuated Live Vaccine 1
Table Introduction of Varicella Attenuated Live Vaccine 1
Table Classification of Varicella Attenuated Live Vaccine 2
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2015 3
Figure Monovalent Vaccine Picture 3
Figure Combination Vaccine Picture 4
Table Applications of Varicella Attenuated Live Vaccine 4
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2015 5
Figure Kids Injection Examples 5
Figure Adults Injection Examples 6
Figure Industry Chain Structure of Varicella Attenuated Live Vaccine 6
Table Global Major Regions Varicella Attenuated Live Vaccine Development Status in 2015 7
Table Industry Policy of Varicella Attenuated Live Vaccine 7
Table Industry News List of Varicella Attenuated Live Vaccine 9
Table Raw Material Suppliers and Price Analysis 11
Table Equipment Suppliers Analysis 11
Figure APAC Overview of Average Monthly Labor Cost in 2015 12
Figure Americas Overview of Average Monthly Labor Cost in 2015 13
Figure EMEA Overview of Average Monthly Labor Cost in 2015 14
Figure Labor Market Risk Score by Country in 2015 14
Figure Coal Monthly Price Analysis 2010-2015 15
Figure Crude Oil (Petroleum) Monthly Price Analysis 2010-2015 16
Figure Natural Gas Price Analysis 2010-2015 16
Table Global Electricity Price of Industry by Country 16
Figure Average Electricity Prices Globally in 2015 18
Table Manufacturing Cost Structure Analysis of Varicella Attenuated Live Vaccine in 2015 19
Figure Manufacturing Process Analysis of Varicella Attenuated Live Vaccine 20
Table Sales Volume (K Doses) and Established date of Global Varicella Attenuated Live Vaccine Major Manufacturers in 2015 21
Table Manufacturing Plants Distribution of Global Varicella Attenuated Live Vaccine Major Manufacturers in 2015 21
Table R&D Status and Technology Source of Global Varicella Attenuated Live Vaccine Major Manufacturers in 2015 22
Table Raw Materials Sources Analysis of Global Varicella Attenuated Live Vaccine Major Manufacturers in 2015 23
Figure Global Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 24
Figure Global Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 25
Table Global Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by
Regions 2011-2016 25
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Regions in 2011 26
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Regions in 2015 26
Table Global Market Size (Value) (M USD) of Varicella Attenuated Live Vaccine by Regions 2011-2016 27
Figure Global Market Size (Value) Share of Varicella Attenuated Live Vaccine by Regions in 2011 27
Figure Global Market Size (Value) Share of Varicella Attenuated Live Vaccine by Regions in 2015 28
Table Global Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2011-2016 28
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2011 29
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2015 30
Table Global Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2011-2016 30
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2011 31
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2015 32
Table Global Sales Volume (K Doses) of Varicella Attenuated Live Vaccine by Companies 2011-2016 32
Table Global Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies 2011-2016 33
Figure Global Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2011 33
Figure Global Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 34
Table Global Sales Revenue (M USD) of Varicella Attenuated Live Vaccine by Companies 2011-2016 34
Table Global Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies 2011-2016 34
Figure Global Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2011 35
Figure Global Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 36
Table Global Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Regions 2011-2016 36
Figure Global Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Regions in 2015 37
Table Global Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies 2011-2016 37
Figure Global Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies in 2015 38
Figure USA Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 39
Figure USA Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 40
Table USA Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2011-2016 40
Figure USA Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2011 41
Figure USA Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2015 42
Table USA Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2011-2016 42
Figure USA Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2011 43
Figure USA Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2015 44
Table USA Sales Volume (K Doses) of Varicella Attenuated Live Vaccine by Companies 2011-2016 44
Figure USA Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 45
Table USA Sales Revenue (M USD) of Varicella Attenuated Live Vaccine by Companies 2011-2016 45
Figure USA Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 46
Table USA Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies 2011-2016 46
Table USA Regional Supply, Import, Export and Consumption of Varicella Attenuated Live Vaccine 2011-2016 (K Doses) 47
Figure Europe Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 48
Figure Europe Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 49
Table Europe Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2011-2016 49
Figure Europe Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2011 50
Figure Europe Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2015 50
Table Europe Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2011-2016 51
Figure Europe Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2011 51
Figure Europe Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2015 52
Table Europe Sales Volume (K Doses) of Varicella Attenuated Live Vaccine by Companies 2011-2016 52
Table Europe Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies 2011-2016 52
Figure Europe Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2011 53
Figure Europe Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 53
Table Europe Sales Revenue (M USD) of Varicella Attenuated Live Vaccine by Companies 2011-2016 54
Table Europe Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies 2011-2016 54
Figure Europe Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2011 54
Figure Europe Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 55
Table Europe Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies 2011-2016 55
Figure Europe Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies in 2015 56
Table Europe Regional Supply, Import, Export and Consumption of Varicella Attenuated Live Vaccine 2011-2016 (K Doses) 56
Figure China Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 57
Figure China Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 58
Table China Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2011-2016 58
Figure China Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2011 59
Figure China Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2015 59
Table China Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2011-2016 60
Figure China Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2011 60
Figure China Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2015 61
Table China Sales Volume (K Doses) of Varicella Attenuated Live Vaccine by Companies 2011-2016 61
Table China Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies 2011-2016 61
Figure China Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2011 62
Figure China Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 63
Table China Sales Revenue (M USD) of Varicella Attenuated Live Vaccine by Companies 2011-2016 63
Table China Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies 2011-2016 63
Figure China Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2011 64
Figure China Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 64
Table China Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies 2011-2016 65
Figure China Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies in 2015 65
Table China Regional Supply, Import, Export and Consumption of Varicella Attenuated Live Vaccine 2011-2016 (K Doses) 66
Figure Japan Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 67
Figure Japan Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2011-2016 68
Table Japan Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2011-2016 68
Figure Japan Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2011 69
Figure Japan Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2015 69
Table Japan Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2011-2016 70
Figure Japan Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2011 70
Figure Japan Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2015 71
Table Japan Sales Volume (K Doses) of Varicella Attenuated Live Vaccine by Companies 2011-2016 71
Table Japan Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies 2011-2016 71
Figure Japan Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2011 72
Figure Japan Sales Volume Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 72
Table Japan Sales Revenue (M USD) of Varicella Attenuated Live Vaccine by Companies 2011-2016 73
Table Japan Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies 2011-2016 73
Figure Japan Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2011 73
Figure Japan Sales Revenue Market Share of Varicella Attenuated Live Vaccine by Companies in 2015 74
Table Japan Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies 2011-2016 74
Figure Japan Sale Price (USD/Dose) of Varicella Attenuated Live Vaccine by Companies in 2015 75
Table Japan Regional Supply, Import, Export and Consumption of Varicella Attenuated Live Vaccine 2011-2016 (K Doses) 75
Table Global 2011-2016E Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Type 76
Table Global 2011-2016E Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Application 78
Table Merck Information List 80
Figure Varicella Attenuated Live Vaccine Picture and Specifications of Merck 81
Figure Varicella Attenuated Live Vaccine Picture and Specifications of Merck 81
Table Varicella Attenuated Live Vaccine Sales Volume (K Doses), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Merck 2011-2016 82
Figure Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Global Market Share of Merck 2011-2016 83
Figure Merck Varicella Vaccine Business Region Distribution in 2015 83
Table GSK Information List 84
Figure Varicella Attenuated Live Vaccine Picture and Specifications of GSK 84
Table Varicella Attenuated Live Vaccine Sales Volume (K Doses), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of GSK 2011-2016 85
Figure Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Global Market Share of GSK 2011-2016 86
Figure GSK Varicella Vaccine Business Region Distribution in 2015 86
Table Shanghai Institute Information List 87
Figure Varicella Attenuated Live Vaccine Picture and Specifications of Shanghai Institute 87
Table Varicella Attenuated Live Vaccine Sales Volume (K Doses), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Shanghai Institute 2011-2016 88
Figure Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Global Market Share of Shanghai Institute 2011-2016 89
Figure Shanghai Institute Varicella Vaccine Business Region Distribution in 2015 89
Table BCHT Information List 90
Figure Varicella Attenuated Live Vaccine Picture and Specifications of BCHT 90
Table Varicella Attenuated Live Vaccine Sales Volume (K Doses), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of BCHT 2011-2016 91
Figure Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Global Market Share of BCHT 2011-2016 92
Figure BCHT Varicella Vaccine Business Region Distribution in 2015 92
Table Changsheng Information List 93
Figure Varicella Attenuated Live Vaccine Picture and Specifications of Changsheng 94
Table Varicella Attenuated Live Vaccine Sales Volume (K Doses), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Changsheng 2011-2016 94
Figure Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Global Market Share of Changsheng 2011-2016 95
Figure Changsheng Varicella Vaccine Business Region Distribution in 2015 96
Table Keygen Information List 96
Figure Varicella Attenuated Live Vaccine Picture and Specifications of Keygen 97
Table Varicella Attenuated Live Vaccine Sales Volume (K Doses), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Keygen 2011-2016 97
Figure Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Global Market Share of Keygen 2011-2016 98
Figure Keygen Varicella Vaccine Business Region Distribution in 2015 98
Table Green Cross Information List 99
Figure Varicella Attenuated Live Vaccine Picture and Specifications of Green Cross 99
Table Varicella Attenuated Live Vaccine Sales Volume (K Doses), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Green Cross 2011-2016 100
Figure Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Global Market Share of Green Cross 2011-2016 101
Figure Green Cross Varicella Vaccine Business Region Distribution in 2015 101
Table Biken Information List 102
Figure Varicella Attenuated Live Vaccine Picture and Specifications of Biken 103
Table Varicella Attenuated Live Vaccine Sales Volume (K Doses), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Biken 2011-2016 104
Figure Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Global Market Share of Biken 2011-2016 104
Figure Biken Varicella Vaccine Business Region Distribution in 2015 105
Table Global Production (K Doses) of Varicella Attenuated Live Vaccine by Regions 2011-2016 106
Table Global Production Market Share of Varicella Attenuated Live Vaccine by Regions 2011-2016 106
Table Global Production Market Share of Varicella Attenuated Live Vaccine by Regions in 2011 107
Table Global Production Market Share of Varicella Attenuated Live Vaccine by Regions in 2015 107
Figure Global Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 108
Figure Global Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 109
Figure USA Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 109
Figure USA Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 110
Figure Europe Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 110
Figure Europe Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 111
Figure China Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 111
Figure China Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 112
Figure Japan Market Size (Volume) (K Doses) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 112
Figure Japan Market Size (Value) (M USD) and Growth Rate of Varicella Attenuated Live Vaccine 2016-2021 113
Table Global Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Regions 2016-2021 113
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Regions in 2016 114
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Regions in 2021 114
Table Global Market Size (Value) (M USD) of Varicella Attenuated Live Vaccine by Regions 2016-2021 115
Figure Global Market Size (Value) Share of Varicella Attenuated Live Vaccine by Regions in 2016 115
Figure Global Market Size (Value) Share of Varicella Attenuated Live Vaccine by Regions in 2021 116
Table Global Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2016-2021 116
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2016 117
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2021 118
Table USA Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2016-2021 118
Figure USA Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2016 119
Figure USA Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2021 120
Table Europe Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2016-2021 120
Figure Europe Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2016 121
Figure Europe Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2021 122
Table China Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2016-2021 122
Figure China Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2021 123
Table Japan Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Types 2016-2021 123
Figure Japan Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2016 124
Figure Japan Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Types in 2021 125
Table Global Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2016-2021 125
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2016 126
Figure Global Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2021 126
Table USA Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2016-2021 127
Figure USA Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2016 127
Figure USA Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2021 128
Table Europe Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2016-2021 128
Figure Europe Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2016 129
Figure Europe Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2021 129
Table China Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2016-2021 130
Figure China Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2016 130
Figure China Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2021 131
Table Japan Market Size (Volume) (K Doses) of Varicella Attenuated Live Vaccine by Applications 2016-2021 131
Figure Japan Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2016 132
Figure Japan Market Size (Volume) Share of Varicella Attenuated Live Vaccine by Applications in 2021 132
Figure Regional Marketing Channels of Varicella Attenuated Live Vaccine 133
Figure International Marketing Channels of Varicella Attenuated Live Vaccine 134
Table Traders or Distributors with Contact Information of Varicella Attenuated Live Vaccine by Regions 134
Table Major Main Raw Materials Suppliers with Contact Information of Varicella Vaccine 136
Table Major Equipment Suppliers with Contact Information of Varicella Vaccine 137
Table the Number of Children Under Five Years Old (Thousand) 138
Table New Project SWOT Analysis of Varicella Attenuated Live Vaccine 139
Table New Project Investment Feasibility Analysis of Varicella Attenuated Live Vaccine 139
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
